Literature DB >> 22582156

Comparative studies of glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1: evidence for a eutherian mammalian origin for the GPIHBP1 gene from an LY6-like gene.

Roger S Holmes, Laura A Cox.   

Abstract

Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1) functions as a platform and transport agent for lipoprotein lipase (LPL) which functions in the hydrolysis of chylomicrons, principally in heart, skeletal muscle and adipose tissue capillary endothelial cells. Previous reports of genetic deficiency for this protein have described severe chylomicronemia. Comparative GPIHBP1 amino acid sequences and structures and GPIHBP1 gene locations were examined using data from several mammalian genome projects. Mammalian GPIHBP1 genes usually contain four coding exons on the positive strand. Mammalian GPIHBP1 sequences shared 41-96% identities as compared with 9-32% sequence identities with other LY6-domain-containing human proteins (LY6-like). The human N-glycosylation site was predominantly conserved among other mammalian GPIHBP1 proteins except cow, dog and pig. Sequence alignments, key amino acid residues and conserved predicted secondary structures were also examined, including the N-terminal signal peptide, the acidic amino acid sequence region which binds LPL, the glycosylphosphatidylinositol linkage group, the Ly6 domain and the C-terminal α-helix. Comparative and phylogenetic studies of mammalian GPIHBP1 suggested that it originated in eutherian mammals from a gene duplication event of an ancestral LY6-like gene and subsequent integration of exon 2, which may have been derived from BCL11A (B-cell CLL/lymphoma 11A gene) encoding an extended acidic amino acid sequence. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s13205-011-0026-4) contains supplementary material, which is available to authorized users.

Entities:  

Year:  2011        PMID: 22582156      PMCID: PMC3339605          DOI: 10.1007/s13205-011-0026-4

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.406


Introduction

Recent studies (Ioka et al. 2003; Beigneux et al. 2007) have shown that a glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1) of capillary endothelial cells is required for the metabolism of triglyceride-rich lipoproteins in mammalian plasma. This glycoprotein binds lipoprotein lipase (LPL) and apolipoproteins (apoA-V) strongly (Gin et al. 2007, 2011) and may serve as a platform for lipolysis within capillaries, particularly in tissues which show high expression levels for both GPIHBP1 and LPL genes, such as heart, skeletal muscle and adipose tissue (Beigneux et al. 2007; Wion et al. 1987; Havel and Kane 2001; Young et al. 2007). Studies of Gpihbp1/Gpihbp1 knock out mice have shown that GPIHBP1-deficiency causes severe hypertriglyceridemia with very high plasma triglyceride levels of 2,000–5,000 mg/dl (Beigneux et al. 2007; Young et al. 2007). Human clinical studies have also examined loss of function GPIHBP1 mutations leading to familial chylomicronemia. Wang and Hegele (2007) reported two siblings with severe chylomicronemia of 160 patients examined exhibiting chylomicronemia who were homozygous for a GPIHBP1 gene missense mutation (G56R). Franssen et al. (2010) and Olivecrona et al. (2010) have recently identified mutations of conserved cysteines (C65S, C65Y and C68G) in the Ly6 domain of GPIHBP1 in familial chylomicronemia, while Beigneux et al. (2009) have reported a mutant GPIHBP1 (Q115P) which lacked the ability to bind LPL and chylomicrons in a patient with chylomicronemia. Biochemical studies (Beigneux et al. 2007; Gin et al. 2007, 2011) have suggested that GPIHBP1 is localized on the luminal and abluminal capillary endothelial cell surfaces where it is bound by a glycosylphosphatidylinositol anchor and binds strongly to LPL. GPIHBP1 serves as an LPL transporter from the sub-endothelial spaces to the luminal face of capillaries, enabling lipolysis of circulating triglycerides localized within plasma chylomicrons (Davies et al. 2010; Fisher 2010). Molecular modeling of human GPIHBP1 (Beigneux et al. 2007) and biochemical analyses (Gin et al. 2007) have shown that this protein contains at least four major domains with distinct roles: an N-terminal signal peptide which targets the intracellular trafficking of GPIHBP1 to the cell surface via the endoplasmic reticulum; a very acidic amino acid domain within the GPIHBP1 amino-terminal region may play a role in binding to the positively charged residues of the heparin-binding domain for LPL and apolipoproteins; a cysteine-rich LY6 domain also contributes to LPL binding, as shown by site-directed mutagenesis and human clinical mutation studies (Franssen et al. 2010; Olivecrona et al. 2010); and a C-terminal region which contains a hydrophobic domain which is replaced by a glycosylphosphotidylinositol anchor within the endoplasmic reticulum and which binds GPIHBP1 to the endothelial cell surface (Nosjean et al. 1997; Fisher 2010; Ory 2007). Recently, Gin et al. (2011) have reported several important GPIHBP1-binding properties and have shown specific binding for LPL whereas other related neutral lipases, hepatic lipase (HL) and endothelial lipase (EL), do not bind. In addition, GPIHBP1 also binds APO-A5 strongly whereas another lipid transport protein (APO-A1) does not. Structures of mammalian n class="Gene">GPIHBP1 genes have been reported in association with a number of mammalian genome sequencing projects, including human, mouse and rat (Mammalian Genome Project Team 2004; Rat Genome Sequencing Project Consortium 2004), and some mammalian GPIHBP1 cDNA and protein sequences have been described (Ioka et al. 2003; Beigneux et al. 2007; Beigneux et al. 2009a, b). Human, mouse and rat GPIHBP1 genes contain four exons of DNA encoding GPIHBP1 sequences (Thierry-Mieg and Thierry-Mieg 2006). This paper describes predicted gene structures and amino acid sequences for several mammalian GPIHBP1 genes and proteins, and predicted secondary structures for mammalian GPIHBP1 proteins. In addition, we examine the relatedness for mammalian GPIHBP1 with other lymphocyte antigen-6 (Ly6-like) genes and proteins, and describe an hypothesis for the origin of the GPIHBP1 gene within eutherian mammals from an ancestral mammalian LY6-like gene and subsequent integration of an exon within the mammalian GPIHBP1 gene encoding the acidic amino acid LPL-binding platform previously described for human and mouse GPIHBP1 (Beigneux et al. 2007; Gin et al. 2007, 2011).

Methods

Mammalian GPIHBP1 gene and protein identification

Basic Local Alignment Search Tool (BLAST) studies were undertaken using web tools from the National Center for Biotechnology Information (NCBI) (http://blast.ncbi.nlm.nih.gov/Blast.cgi) (Altschul et al. 1997). Protein BLAST analyses used mammalian GPIHBP1 amino acid sequences previously described (Table 1). Non-redundant protein sequence databases for several mammalian genomes were examined using the blastp algorithm, including human (Homo sapiens) (International Human Genome Consortium 2001); chimpanzee (Pan troglodytes) (Chimpanzee Sequencing and Analysis Consortium 2005); orangutan (Pongo abelii) (http://genome.wustl.edu); rhesus monkey (Macaca mulatta) (Rhesus Macaque Genome Sequencing and Analysis Consortium 2007), cow (Bos Taurus) (Bovine Genome Project 2008); horse (Equus caballus) (Horse Genome Project 2008); mouse (Mus musculus) (Mouse Genome Sequencing Consortium 2002); rat (Rattus norvegicus) (Rat Genome Sequencing Project Consortium 2004); opossum (Monodelphis domestica) (Mikkelsen et al. 2007); and platypus (Ornithorhynchus anatinus) (Warren et al. 2008). This procedure produced multiple BLAST ‘hits’ for each of the protein databases which were individually examined and retained in FASTA format, and a record kept of the sequences for predicted mRNAs and encoded GPIHBP1-like proteins. These records were derived from annotated genomic sequences using the gene prediction method: GNOMON and predicted sequences with high similarity scores for human GPIHBP1. Predicted GPIHBP1-like protein sequences were obtained in each case and subjected to analyses of predicted protein and gene structures.
Table 1

Mammalian GPIHBP1 and human LY6-like genes and proteins

GPIHBP1 geneSpeciesRefSeq ID EnsemblaGenBank IDUNIPROT IDAmino acidsChromosome locationCoding exonsGene size bpsSubunit MWSignal peptide (cleavage site)Gene expression levelf
Human Homo sapiens NM_178172BC035810Q8IV161848:144,295,143-144,297,3904 (+ve)3,97619,8061-20 [RG-QT]0.4
Chimpanzee Pan troglodytes XP_001151889abb1668:143,181,557-143,183,7864 (+ve)2,230c17,5401-20 [RG-QT]na
Orangutan Pongo abelii XP_002819549abb1848:151,582,751-151,585,2755 (+ve)2,525c19,7781-20 [RG-QT]na
Rhesus Macaca mulatta XP_001085384abb1848:145,833,092-145,835,2374 (+ve)2,146c19,7681-22 [QA-QQ]na
Marmoset Callithrix jacchus XP_002759233abb18216:51,444,208-51,447,3574 (−ve)3,150c19,9931-22 [QA-EP]na
Mouse Mus musculus NM_026730BC061225Q9D1N222515:75,427,109-75,428,5514 (+ve)1,55624,5661-22 [WA-QE]0.7
Rat Rattus norvegicus NM_001130547bb2367:113,538,462-113,540,1374 (+ve)1,676c25,5621-22 [WA-QE]0.1
Guinea pig Cavia porcellus ENSCPOT2066dbb167sc95:2379881-2381261e4 (+ve)1,381c18,2401-22 [QA-QE]na
Horse Equus caballus XP_001496557abb1769:81,888,709-81,890,4894 (+ve)1,781c19,0031-20 [SG-QV]na
Cow Bos taurus XP_590408abb17114:1,462,446-1,464,2194 (+ve)1,774c17,9901-22 [RA-QE]na
Dog Canis familaris XP_851590bb18013:136,185,964-136,187,7864 (+ve)1,482c18,3831-20 [RA-QD]na
Pig Sus scrofa bCF361073db1804:136,185,964-136,187,7864 (−ve)1,823c19,2741-22 [RA-QE]na
LY6-like gene
 PSCA Homo sapiens NM_005672BC048808O466531238:143,748,728-143,761,1533 (+ve)2,26812,9121--20 [TA-LL]1.2
 LY6K Homo sapiens NM_017527BC117142Q17RY61658:143,781,946-143,784,7863 (+ve)4,05418,6731-17 [WT-DA]0.9
 SLURP1 Homo sapiens NM_020427BC105135P550001038:143,822,564-143,823,8033 (−ve)1,46711,1861-22 [EA-LK]0.1
 LYPD2 Homo sapiens NM_205545BC119019Q6UXB31258:143,831,704-143,833,8693 (−ve)2,23413,1151-22 [PA-LR]0.1
 LYNX1 Homo sapiens NM_177476BC032036Q9BZG91168:143,856,588-143,857,3753 (−ve)5,82312,6411-20 [QA-LD]1.8
 LY6D Homo sapiens NM_003695BC031330B2R5F11288:143,865,011-143,863,2943 (−ve)1,71113,2861-20 [LT-LR]0.6
 GML Homo sapiens NM_002066BC126336Q994451588:143,916,217-143,928,2613 (+ve)6,25017,7301-17 [AA-SA]<0.1
 LY6E Homo sapiens NM_001127213BC119708Q165531318:144,102,357-144,103,2033 (+ve)3,92613,5071-20 [SS-LM]4.3
 LY6H Homo sapiens NM_002347BC030192B2RAD21408:144,239,670-144,241,0653 (−ve)2,12614,6691-25 [HG-LW]0.7
 GPIBP1 Homo sapiens NM_178172BC035810Q8IV161848:144,295,143-144,297,3904 (+ve)3,97619,8061-20 [RG-QT]0.4

GenBank IDs are derived from NCBI http://www.ncbi.nlm.nih.gov/genbank/, Ensembl ID was derived from Ensembl genome database http://www.ensembl.org, UNIPROT refers to UniprotKB/Swiss-Prot IDs for individual proteins (see http://kr.expasy.org), bps refers to base pairs of nucleotide sequences; the number of coding exons are listed, the predicted signal N-peptide cleavage site is listed

RefSeq The reference amino acid sequence

a,cPredicted Ensembl amino acid sequence

bNot available

dRefers to an expressed sequence tag (EST) sequence encoding pig GPIHBP1

eGuinea pig scaffold

fFrom AceView http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/

Mammalian GPIHBP1 and human LY6-like genes and proteins GenBank IDs are derived from NCBI http://www.ncbi.nlm.nih.gov/genbank/, Ensembl ID was derived from Ensembl genome database http://www.ensembl.org, Un class="Chemical">NIPROT refers to UniprotKB/Swiss-Prot IDs for individual proteins (see http://kr.expasy.org), bps refers to base pairs of nucleotide sequences; the number of coding exons are listed, the predicted signal N-peptide cleavage site is listed RefSeq The reference amino acid sequence a,cPredicted Ensembl amino acid sequence bNot available dRefers to an expressed sequence tag (EST) sequence encoding pig GPIHBP1 eGuinea pig scaffold fFrom AceView http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/ Blast-Like Alignment Tool (BLAT) analyses were subsequently undertaken for each of the predicted GPIHBP1 amino acid sequences using the University of California Santa Cruz (UCSC) Genome Browser [http://genome.ucsc.edu/cgi-bin/hgBlat] (Kent et al. 2003) with the default settings to obtain the predicted locations for each of the mammalian GPIHBP1 genes, including predicted exon boundary locations and gene sizes. BLAT analyses were similarly undertaken for other mammalian LY6-like and vertebrate BCL11A-like (encoding B-cell CLL/lymphoma 11A) genes and proteins using previously reported sequences for LY6D, LY6E, LY6H, LY6K, LY6NX1, PSCA, SLURP1, GML, LY6D2 and BCL11A in each case (Tables 1, 2, 3). Structures for human, mouse and rat GPIHBP1 genes and encoded proteins were obtained using the AceView website Thierry-Mieg and Thierry-Mieg 2006) (http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/index.html?human).
Table 2

Mouse, cow, opossum and zebrafish LY6-like genes and proteins

LY6-like geneSpeciesRefSeq ID EnsemblaGenBank IDUNIPROT IDAmino acidsChromosome locationCoding exons (strand)Gene size bps
Psca Mus musculus NP_082492aBC110462Q9D7U012315:74,545,285-74,547,0243 (+ve)2,231
Slurp1 NM_020519BC125244Q9Z0K711015:74,558,464-74,554,0393 (−ve)1,383
Lypd2 NM_026671BC132407Q9DD2312715:74,564,759-74,562,6713 (−ve)1,951
Lynx1 NP_035968aBC037541Q9WVC211615:74,583,477-74,578,2723 (−ve)673
Ly6d NP_034872aBC022806Q1421012715:74,592,789-74,593,9903 (−ve)1,202
Ly6o EDL29447aBC055822na11915:74,602,554-74,609,2683 (−ve)6,715
Ly6k NM_029627BC049723Q9CWP415415:74,630,417-74,627,2983 (−ve)2,510
Ly6p NM_025929BC116397Q9CQ1111115:74,710,281-74,712,0953 (−ve)1,815
Ly6e NM_008529BC002116Q99JA513615:74,785,480-74,790,3363 (+ve)903
Ly6i NM_020498BC125390Q9WU6713415:74,810,347-74,813,4893 (−ve)3,143
Ly6a NM_010738BC002070P0553313415:74,825,695-74,828,0343 (−ve)2,340
Ly6c1 NM_010741BC010760Q91XG013115:74,875,445-74,879,2603 (−ve)3,107
Ly6c2 NM_001099217BC092082P0956813115:74,938,976-74,942,0973 (−ve)3,122
Ly6f NM_008530BC152856P3546013415:75,099,160-75,102,2773 (+ve)3,118
Ly6h NM_011837BC028758Q8K35613915:75,397,918-75,381,6983 (−ve)1,090
Slurp1 Bos taurus XP_002692640anana12614:1,122,649-1,123,7764 (−ve)1,128
LYPD2 XP_001256661anana12814:1,127,319-1,129,2013 (−ve)1,883
LYNX1 NP_001039686anana11614:1,141,889-1,142,6343 (−ve)746
LY6D NP_001069985anana11614:1,155,662-1,156,8203 (−ve)1,159
GML1 DAA72886anana15414:1,219,764-1,228,3634 (−ve)8,600
GML2 NP_001070493anana15414:1,258,190-1,265,3263 (−ve)7,137
LY6E NP_001039535anana13014:1,387,941-1,388,6893 (+ve)749
LY6H NP_001073104anana14014:1,449,309-1,450,7503 (−ve)1,442
SLURP Monodelphis domestica XP_001381780anana1323:428,776,701-428,782,6243 (−ve)5,924
LYPD2 XP_001381786anana2373:428,806,270-428,813,2474 (−ve)6,978
LYNX1 XP_001381791anana1623:428,858,073-428,880,9373 (−ve)22,865
LYNX2 XP_001381798anana1203:428,958,198-428,965,1103 (−ve)6,913
LY6D XP_001381801anana1173:428,986,162-428,995,1183 (−ve)8,957
LY6H1 XP_001373482anana1263:439,197,554-439,200,0633 (+ve)2,510
LY6H2 XP_001373600anana1413:439,414,602-439,420,6863 (+ve)6,085
LYPD6 Danio rerio NM_001004670BC081426Q66IA61749:24,104,899-24,151,6954 (−ve)46,797

Ensembl ID was derived from Ensembl genome database http://www.ensembl.org, UNIPROT refers to UniprotKB/Swiss-Prot IDs for individual proteins (see http://kr.expasy.org), bps refers to base pairs of nucleotide sequences, the number of coding exons are listed

RefSeq The reference amino acid sequence

aPredicted Ensembl amino acid sequence

Table 3

Vertebrate BCL11A genes and proteins

Mammalian BCL11A GeneSpeciesRefSeq ID EnsemblaGenBank IDUNIPROT IDAmino acidsChromosome locationCoding exons (strand)Gene size bps
Human Homo sapiens NM_018014BC021098Q9H1657732:60,678,303-60,780,6335 (−ve)102,331
Orangutan Pongo abelii XP_002812058anana8082:50,366,387-50,465,1546 (+ve)98,768
Marmoset Callithrix jacchus XP_002757779anana80814:46,690,157-46,792,3846 (+ve)102,228
Mouse Mus musculus NM_016707BC010585Q9QYE377311:23,978,391-24,072,7875 (+ve)94,397
Pig Sus scrofa XP_003125157aAK231444na7733:74,933,998-75,031,7715 (+ve)97,774
Rabbit Oryctolagus cuniculus XP_002709742anana8212:125,646,621-125,730,5214 (+ve)83,901
Dog Canis familiaris XP_865536anana77310:63,737,516-63,836,8525 (−ve)99,337
Chicken Gallus gallus NM_001031031AJ551441Q5F4597963:1,829,458-1,877,7843 (−ve)48,237
Lizard Anolis carolinensis XP_003216184anana796276:252,030-507,710b3 (+ve)255,681
Zebrafish Danio rerio NP_001035481anaA2BE8482913:26,077,202-26,148,7703 (+ve)71,569

BCL11A refers to the gene encoding vertebrate B-cell CLL/lymphoma 11A sequences

Ensemble ID was derived from Ensembl genome database http://www.ensembl.org; UNIPROT refers to UniprotKB/Swiss-Prot IDs for individual proteins (see http://kr.expasy.org); bps refers to base pairs of nucleotide sequences; the number of coding exons are listed

RefSeq The reference amino acid sequence

aPredicted Ensembl amino acid sequence

bRefers to scaffold ID

Mouse, cow, opossum and zebrafish LY6-like genes and proteins Ensembl ID was derived from Ensembl genome database http://www.ensembl.org, UNIPROT refers to UniprotKB/Swiss-Prot IDs for individual proteins (see http://kr.expasy.org), bps refers to base pairs of nucleotide sequences, the number of coding exons are listed RefSeq The reference amino acid sequence aPredicted Ensembl amino acid sequence Vertebrate BCL11A genes and proteins BCL11A refers to the gene encoding vertebn class="Species">rate B-cell CLL/lymphoma 11A sequences Ensemble ID was derived from Ensembl genome database http://www.ensembl.org; UNIPROT refers to UniprotKB/Swiss-Prot IDs for individual proteins (see http://kr.expasy.org); bps refers to base pairs of nucleotide sequences; the number of coding exons are listed RefSeq The reference amino acid sequence aPredicted Ensembl amino acid sequence bRefers to scaffold ID

Predicted structures, properties and alignments of mammalian GPIHBP1 and human LY6-like sequences

Predicted secondary structures for human and other n class="Species">mammalian GPIHBP1 proteins were obtained using the PSIPRED v2.5 website tools [http://bioinf.cs.ucl.ac.uk/psipred/psiform.html] (McGuffin et al. 2000). Other web tools were used to predict the presence and locations of the following for each of the mammalian GPIHBP1 sequences: SignalP 3.0 for signal peptide cleavage sites (http://www.cbs.dtu.dk/services/SignalP/) (Emmanuelsson et al. 2007); NetNGlyc 1.0 for potential N-glycosylation sites (http://www.cbs.dtu.dk/services/NetNGlyc/); and big-PI Predictor for the glycosylphosphatidylinositol linkage group-anchored sites (http://mendel.imp.ac.at/sat/gpi/gpi_server.html) (Eisenhaber et al. 1998). The reported tertiary structure for human CD59 (membrane-bound glycoprotein) (Leath et al. 2007) served as the reference for the predicted human, rat, pig and guinea pig GPIHBP1 tertiary structures, with modeling ranges of residues 62–138, 69–146, 65–141 and 61–139, respectively. Alignments of mammalian GPIHBP1 sequences with human LY6D, LY6E, LY6H, LY6K, LYNX1 and LYPD2 lymphocyte antigen-6-related proteins or with vertebrate B-cell CLL/lymphoma 11A (BCL11A) sequences were assembled using the ClustalW2 multiple sequence alignment program (Larkin et al. 2007) (http://www.ebi.ac.uk/Tools/clustalw2/index.html).

Comparative bioinformatics of mammalian GPIHBP1, vertebrate LY6-like and vertebrate BCL11A genes and proteins

The UCSC Genome Browser (http://genome.ucsc.edu) (Kent et al. 2003) was used to examine comparative structures for mammalian GPIHBP1 (Table 1), vertebrate LY6-like (lymphocyte antigen-6 complex; Tables 1, 2) and vertebrate BCL11A (B-cell CLL/lymphoma 11A) (Table 3) genes and proteins. We also used the UCSC Genome Browser Comparative Genomics track that shows alignments of up to 28 vertebrate species and evolutionary conservation of GPIHBP1 gene sequences. Species aligned for this study included 4 primates, 6 non-primate eutherian mammals (e.g., mouse, rat), a marsupial (opossum), a monotreme (platypus) and bird species (chicken). Conservation measures were based on conserved sequences across all of these species in the alignments which included the 5′-flanking, 5′-untranslated and coding regions of the GPIHBP1 gene. BLAT analyses were subsequently undertaken using the nucleotide sequence for exon 2 of human GPIHBP1 using the UCSC Genome Browser [http://genome.ucsc.edu/cgi-bin/hgBlat] (Kent et al. 2003) to identify homologs for this exon in the human genome.

Phylogenetic studies and sequence divergence

Alignments of mammalian GPIHBP1 and vertebrate LY6-like protein sequences were assembled using BioEdit v.5.0.1 and the default settings (Hall 1999). Alignment ambiguous regions, including the acidic amino acid region of GPIHBP1, were excluded prior to phylogenetic analysis yielding alignments of 60 residues for comparisons of sequences with the zebrafish (Danio rerio) LY6-like (LYPD6) sequence (Tables 1, 2). Evolutionary distances were calculated using the Kimura option (Kimura 1983) in TREECON (Van De Peer and de Wachter 1994). Phylogenetic trees were constructed from evolutionary distances using the neighbor-joining method (Saitou and Nei 1987) and rooted with the zebrafish LYPD6 sequence. Tree topology was reexamined by the bootstrap method (100 bootstraps were applied) of resampling and only values that were highly significant (≥90) are shown (Felsenstein 1985).

Results and discussion

Alignments of mammalian GPIHBP1 amino acid sequences with human LY6-related antigen sequences

The deduced amino acid sequences for orangutan (Pongo abelii), rhesus monkey (Macaca mulatta), marmoset (Callithrix jacchus), horse (Equus caballus), cow (Bos taurus) and rat (Rattus norvegicus) GPIHBP1 are shown in Fig. 1 together with previously reported sequences for human and mouse GPIHBP1 (Beigneux et al. 2007; Gin et al. 2007). In addition, amino acid sequences for several LY6-related lymphocyte antigen sequences are also aligned with the mammalian GPIHBP1 sequences, including human LY6D (Brakenoff et al. 1995), LY6E (Capone et al. 1996), LYPD2 (Clark et al. 2003), LY6H (Horie et al. 1998), LY6K (Ishikawa et al. 2007) and LYNX1 (Mammalian Genome Project Team 2004) (Table 1). Alignments of human and other mammalian GPIHBP1 sequences examined showed identities between 46 and 96%, suggesting that these are the products of the same gene family, whereas comparisons of sequence identities of mammalian GPIHBP1 proteins with human LY6-like lymphocyte antigen sequences exhibited low levels of sequence identities (9–32%), indicating that these are the members of distinct protein families (Table 4).
Fig. 1

Amino acid sequence alignments for mammalian GPIHBP1 and human LY6-like sequences. See Table 1 for sources of glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1) and human LY6-like sequences: GPIHBP1—Hu human, Or orangutan, Rh rhesus, Ma marmoset, Ho horse, Co cow, Mo mouse, Ra rat; Human LY6-like: 6D-LY6D; 6E-LY6E; 6D2-LY6D2; 6H-LY6H; 6K-LY6K; 6NX-LY6NX. Asterisks show identical residues for proteins, colon similar alternate residues, dot dissimilar alternate residues. Residues predicted for involvement in N-signal peptide formation are shown in red, N-glycosylated and potential N-glycosylated Asn sites are in green bold, key GPIHBP1 functional residues 56Gly and 114Gln are in shaded pink, predicted disulfide bond Cys residues are shown; α-helices predicted for GPIHBP1 are in shaded yellow, β-sheets (β1–β5) predicted for mammalian GPIHBP1 or for human LY6-like sequences are in shadedgrey, bold underlined font shows residues corresponding to known or predicted exon start sites. Exon numbers refer to GPIHBP1 human gene exons, the sequences for the UPAR/Ly6 domain are shown, C-terminal hydrophobic amino acid segment is shown as shadedgreen, known (human and mouse) or predicted mammalian GPIHBP1 and human LY6-like GPI-binding sites are shown in shadedblue

Table 4

Percentage identities for mammalian GPIHBP1 amino acid sequences and the human LY6-like amino acid sequences

GPIHBP1HumanOrangutanRhesusMarmosetMouseRatGuinea pigDogPigCowHorseHumanHumanHumanHumanHumanHuman
LY6DLY6ELY6HLY6KLYPD2LYNX1
Human10096848054525360535459142726102413
Orangutan96100858454535361545560172423102413
Rhesus84851007353535157504959103025132412
Marmoset8084731004650515751465718272292312
Mouse5454534610082635351505514202292514
Rat52535350821006151495251152021131525
Guinea pig535351516361100414143489161761816
Dog60615757535141100565664163126182818
Pig53545051514941561006556202625172215
Cow54554946505243566510060162525202114
Horse5960595755514864566010020292582416
Human LY6D1417101814159162016201002530143228
Human LY6E27243027202016312625292510032191732
Human LY6H26232522222117262525253032100162825
Human LY6K1010139913618172081419161002218
Human LYPD224242423251518282221243217282210031
Human LYNX113131212142516181514162832251831100

Numbers show the percentage of amino acid sequence identities

Amino acid sequence alignments for mammalian n class="Gene">GPIHBP1 and human LY6-like sequences. See Table 1 for sources of glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1) and human LY6-like sequences: GPIHBP1—Hu human, Or orangutan, Rh rhesus, Ma marmoset, Ho horse, Co cow, Mo mouse, Ra rat; Human LY6-like: 6D-LY6D; 6E-LY6E; 6D2-LY6D2; 6H-LY6H; 6K-LY6K; 6NX-LY6NX. Asterisks show identical residues for proteins, colon similar alternate residues, dot dissimilar alternate residues. Residues predicted for involvement in N-signal peptide formation are shown in red, N-glycosylated and potential N-glycosylated Asn sites are in green bold, key GPIHBP1 functional residues 56Gly and 114Gln are in shaded pink, predicted disulfide bond Cys residues are shown; α-helices predicted for GPIHBP1 are in shaded yellow, β-sheets (β1–β5) predicted for mammalian GPIHBP1 or for human LY6-like sequences are in shadedgrey, bold underlined font shows residues corresponding to known or predicted exon start sites. Exon numbers refer to GPIHBP1 human gene exons, the sequences for the UPAR/Ly6 domain are shown, C-terminal hydrophobic amino acid segment is shown as shadedgreen, known (human and mouse) or predicted mammalian GPIHBP1 and human LY6-like GPI-binding sites are shown in shadedblue Percentage identities for mammalian GPIHBP1 amino acid sequences and the human LY6-like amino acid sequences Numbers show the percentage of amino acid sequence identities The amino acid sequences for most of the mammalian n class="Gene">GPIHBP1 proteins contained 167–184 residues whereas mouse and rat GPIHBP1 contained 225 and 236 amino acids, respectively, with the latter having extended C-terminal sequences (Fig. 1). Previous biochemical and genetic analyses of human and mouse GPIHBP1 (Beigneux et al. 2007; Gin et al. 2007, 2011) have enabled predictions of key residues for these mammalian GPIHBP1 proteins (sequence numbers refer to human GPIHBP1). These included the N-terminus signal peptide (residues 1–20) which participates in the trafficking of GPIHBP1 via the endoplasmic reticulum; two acidic amino acid clusters (residues 25–32 and 41–50) which may contribute to LPL binding within a basic amino acid LPL heparin-binding site region (Sendak and Bensadoun 1998); a conserved Gly56 with an unknown function (Gin et al. 2007); a predominantly conserved N-glycosylation site (Asn78-Leu79-Thr80) which is critical for the movement of GPIHBP1 onto the cell surface (Beigneux et al. 2008); a urokinase plasminogen activator receptor (UPAR)-lymphocyte antigen-6 (LY6) domain which contains 10 conserved cysteine residues (Cys65, Cys68, Cys77, Cys83, Cys89, Cys110, Cys114, Cys130, Cys131 and Cys136) and forms five disulfide bridges within this domain; Gln115 which plays a role in LPL binding to GPIHBP1 (Franssen et al. 2010); and a hydrophobic C-terminal helix domain (residues 160–178) which is replaced by a glycosylphosphatidylinositol anchor (to Gly159) and is responsible for linking GPIHBP1 to the endothelial cell surface (Nosjean et al. 1997; Davies et al. 2010; Fisher 2010). These residues and predicted properties were conserved for all of the mammalian GPIHBP1 sequences examined (Fig. 1) with the exception of the cow GPIHBP1 sequence, which lacked a predicted N-glycosylation site (Beigneux et al. 2008). Predicted N-glycosylation site(s) were also absent in guinea pig, dog and pig GPIHBP1 sequences; whereas human and orangutan GPIHBP1 sequences exhibited two predicted N-glycosylation sites (Asn78-Leu79-Thr80 and Asn82-Cys83-Ser84) (Table 5) although experimental evidence for in vivo N-glycosylation is only available for the first site (Beigneux et al. 2008).
Table 5

Predicted N-glycosylation sites for mammalian GPIHBP1 sequences

Mammalian GPIHBP1SpeciesSite 1Site 1 potentialSite 2Site 2 potentialSite 3Site 3 potentialSite 4Site 4 potentialNo. of potential sites
Human Homo sapiens 78NLTQ 0.76 82NCSH 0.61 2
Orangutan Pongo abelii 78NLTQ 0.76 82NCSH 0.61 2
Rhesus Macaca mulatta 78NLTR 0.69 1
Marmoset Callithrix jacchus 77NLTQ 0.80 1
Mouse Mus musculus 76NQTQ 0.53 1
Rat Rattus norvegicus 84NETQ 0.55 1
Guinea Pig Cavia porcellus 76NQTENP150NGTTNP0
Horse Equus caballus 77NQTQ 0.68 118NKTV 0.70 2
Cow Bos taurus 0
Dog Canis familaris 0
Pig Sus scrofa 0

Predicted N-glycosylation sites were identified using NetNGlyc 1.0 web tools (http://www.cbs.dtu.dk/services/NetNGlyc/)³², potential for N-glycosylation sites was determined by the web tools (maximum level of 1)

Bold values designate high probability of forming an N-glycosylation site

N Asparagine, L leucine, Q glutamine, T threonine, C cysteine, R arginine, E glutamate, H histidine, V valine, NP no prediction for an N-glycosylation site

Predicted N-glycosylation sites for mammalian GPIHBP1 sequences Predicted N-glycosylation sites were identified using NetNGlyc 1.0 web tools (http://www.cbs.dtu.dk/services/NetNGlyc/)³², potential for N-glycosylation sites was determined by the web tools (maximum level of 1) Bold values designate high probability of forming an N-glycosylation site N Asparagine, L leucine, Q glutamine, T threonine, C cysteine, R arginine, E glutamate, H histidine, V valine, NP no prediction for an N-glycosylation site The human n class="Chemical">LY6-like sequences examined shared several of the mammalian GPIHBP1 domain regions, including the N-signal peptide region (sequence numbers refer to human LY6D) (residues 1–20); the UPAR-LY6 domain with 10 conserved cysteine residues (Cys23, Cys26, Cys32, Cys38, Cys45, Cys63, Cys67, Cys86, Cys87 and Cys92) forming five disulfide bonds previously reported for LY6-like proteins (Fry et al. 2003; Leath et al. 2007), and the hydrophobic C-terminal helix domain (residues 104–125) which is replaced by a glycosylphosphatidylinositol anchor (predicted to be bound to Asn98). These LY6-like sequences, however, lacked the N-terminal acidic amino acid domain and contained fewer amino acids in the protein region surrounding the UPAR-Ly6 domain (residues 21–96). These sequences also lacked the predominantly conserved N-glycosylation site observed for mammalian GPIHBP1 proteins but contained amidation sites for attaching the glycosylphosphatidylinositol anchor in each case.

Predicted structures for mammalian GPIHBP1 proteins

Predicted secondary structures for mammalian GPIHBP1 sequences were compared with those predicted for human lymphocyte antigen-6-like proteins (Fig. 1). α-Helix and β-sheet structures for these sequences were similar for several regions with the human LY6-like secondary structures, including the N-terminal signal peptide which contained an extended helical structure; the UPAR-LY6 domain which contained four or five β-sheet structures (designated as β1–β5) within the region for five disulfide bonds; and the C-terminal hydrophobic region, which is removed following GPI-attachment within the endoplasmic reticulum. The distinctive secondary structures observed for mammalian GPIHBP1 sequences were two acidic amino acid α-helical regions which were notably absent in the LY6-like predicted secondary structures. Tertiary structures for the members of the LY6 protein family has been reported previously which are characterized by an amino acid motif containing eight or ten cysteine residues arranged in consistent spacing patterns forming four or five disulfide bonds and a three-finger motif which comprised β-pleated sheets predominantly. The predicted secondary structures observed for the human LY6-like proteins (LY6D, LY6E, LY6PD, LY6H, LY6K and LY6NX1) and the mammalian GPIHBP1 protein sequences examined are consistent with the presence of this LY6 protein family motif within these proteins (Fig. 1). Figure 2 describes predicted tertiary structures for human, rat, pig (Sus scrofa) and guinea pig (Cavia porcellus) GPIHBP1 protein sequences and shows significant similarities to the UPAR-LY6 domain reported for the human CD59 antigen (membrane-bound glycoprotein) (Leath et al. 2007). Five anti-parallel β-sheets are readily apparent in each case, which is consistent with the predictions observed for the human and rat GPIHBP1 proteins shown in the amino acid sequence alignments in Fig. 1. This suggests that the UPAR-LY6 domain secondary and tertiary structures are shared among all GPIHBP1 proteins examined as well as the human LY6-like proteins examined.
Fig. 2

Predicted tertiary structures for the UPAR/Ly6 domain for human, rat, guinea pig and pig GPIHBP1. Predicted GPIHBP1 tertiary structures were obtained using SWISS MODEL methods; the rainbow color code describes the tertiary structures from the N- (blue) to C-termini (red color) for human, rat, guinea pig and pig GPIHBP1 UPAR/Ly6 domains; arrows indicate the directions for β-sheets

Predicted tertiary structures for the UPAR/Ly6 domain for n class="Species">human, rat, guinea pig and pig GPIHBP1. Predicted GPIHBP1 tertiary structures were obtained using SWISS MODEL methods; the rainbow color code describes the tertiary structures from the N- (blue) to C-termini (red color) for human, rat, guinea pig and pig GPIHBP1 UPAR/Ly6 domains; arrows indicate the directions for β-sheets The overall structure for mammalian GPIHBP1 may then comprise the two α-helices of acidic amino acids (which bind LPL to GPIHBP1) and the three-fingered β-sheet motif which is covalently linked to the plasma membrane by a glycosylphosphatidylinositol anchor. Recent studies have shown that both motifs are essential for LPL binding and transport and for GPIHBP1 function (Beigneux et al. 2009a, b; Gin et al. 2011).

Comparative human GPIHBP1 tissue expression

Beigneux et al. (2009b) have previously examined Gpihbp1 tissue expression in mouse tissues and reported high levels of expression in heart and adipose tissue, which corresponds with the major distribution for LPL in the body and supports the key role played by this enzyme in lipid metabolism, especially in heart and adipose tissue (Wion et al. 1987; Havel and Kane 2001). Overall, human GPIHBP1, and mouse and rat Gpihbp1 genes were moderately expressed in comparison with the other lymphocyte antigen-like genes being 0.1–0.7 times the average level of gene expression in comparison with human LY6E and LYNX1 genes, which showed expression levels of 4.3 and 1.8 times the average gene, respectively (Table 1). This may reflect a more restricted GPIHBPI cellular expression as compared with LY6-like genes and/or a more specialized role of GPIHBP1 is being responsible for LPL binding in heart and adipose tissue as compared with the broader and more widely distributed functions of LY6-like proteins as lymphocyte antigens throughout the body.

Gene locations and exonic structures for mammalian GPIHBP1 genes and human LY6-like genes

Table 1 summarizes the predicted locations for mammalian GPIHBP1 genes and human LY6-like genes based on BLAT interrogations of several mammalian genomes using the reported sequences for human and mouse (Beigneux et al. 2007; Gin et al. 2007, 2011) and the predicted sequences for the other mammalian GPIHBP1 proteins and the UCSC Genome Browser (Kent et al. 2003). Table 2 also presents the predicted locations and other features for mouse, cow and opossum LY6-like genes and proteins. The mammalian GPIHBP1 genes were predominantly transcribed on the positive strand, with the exception of the marmoset and pig genes which were transcribed on the negative strand. Figure 1 summarizes the predicted exonic start sites for mammalian GPIHBP1 genes with most having 4 coding exons in identical or similar positions to those predicted for the human GPIHBP1 gene, with the exception of the orangutan GPIHBP1 gene, which contained an additional exon within the encoding region for the C-terminal sequence. In contrast, the human, mouse, cow and opossum LY6-like genes examined contained only 3 coding exons encoded on either the positive or negative strands. These results are indicative of structural similarities between the mammalian GPIHBP1 and LY6-like genes but with the GPIHBP1 genes possessing an additional exon (exon 2) in each case. Figure 3 summarizes the comparative locations of human, rhesus monkey, mouse, cow and opossum LY6-like genes within respective gene clusters. Nine human and rhesus LY6-like and the related GPIHBP1 genes, for example, were localized within 535 or 618 kb gene clusters, respectively, on human and rhesus chromosome 8 whereas 15 mouse Ly6-like genes and the Gpihbp1 gene were co-localized within a 883-kb gene cluster on mouse chromosome 15. Cow and opossum (Monodelphis domestica—a marsupial mammal) LY6-like genes were also similarly located within respective gene clusters on chromosomes 14 and 3, respectively, although in each case, there were fewer LY6-like genes identified in comparison with human and rhesus genomes, and particularly the mouse genome. Of special interest to this current study, however, is the absence of an identified opossum GPIHBP1-like gene and the presence of two predicted opossum LY6H-like genes on chromosome 3 of the opossum genome. For each of the mammalian genomes examined (human, rhesus monkey, mouse, cow and opossum), there were similarities in LY6-like gene order: LYPD2-LYNX1-LY6D-LY6E-LY6H-GPIHBP1, but with GPIHBP1 being undetected in the case of the opossum genome.
Fig. 3

Comparative gene clusters for mammalian LY6-like genes. LY6-like gene clusters are identified with the size of the cluster (in kilobases) in each case. Individual LY6-like genes were identified and positioned using data summarized in Tables 1 and 2. The arrow shows the direction for transcription:right arrow the positive strand; left arrow the negative strand. Note the absence of an identified GPIHBP1 gene on the opossum genome

Comparative gene clusters for mammalian LY6-like genes. LY6-like gene clusters are identified with the size of the cluster (in kilobases) in each case. Individual LY6-like genes were identified and positioned using data summarized in Tables 1 and 2. The arrow shows the direction for transcription:right arrow the positive strand; left arrow the negative strand. Note the absence of an identified GPIHBP1 gene on the opossum genome Figure 4 shows the predicted structures of mRNAs for human, mouse and rat GPIHBP1 transcripts (Thierry-Mieg and Thierry-Mieg 2006) which were 2.3–3.1 kbs in length with three introns and four exons present and in each case, an extended 3′-untranslated region (UTR) was observed.
Fig. 4

Gene and mRNA structures for the human, mouse and rat GPIHBP1 genes. Derived from the AceView website http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/ (Thierry-Mieg and Thierry-Mieg 2006); mature isoform variants (a) are shown with capped 5′- and 3′-ends for the predicted mRNA sequences. NM refers to the NCBI reference sequence. Exons are in shaded pink; untranslated 5′- and 3′ sequences are in open pink, introns are represented as pink lines joining exons, the directions for transcription are shown as 5′→3′, sizes of mRNA sequences are shown in kilobases (kb)

Gene and mRNA structures for the human, mouse and rat GPIHBP1 genes. Derived from the AceView website http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/ (Thierry-Mieg and Thierry-Mieg 2006); mature isoform variants (a) are shown with capped 5′- and 3′-ends for the predicted mRNA sequences. NM refers to the NCBI reference sequence. Exons are in shaded pink; untranslated 5′- and 3′ sequences are in open pink, introns are represented as pink lines joining exons, the directions for transcription are shown as 5′→3′, sizes of mRNA sequences are shown in kilobases (kb)

Evolutionary appearance of the GPIHBP1 gene in mammalian genomes

Figure 5 shows a UCSC Genome Browser Comparative Genomics track that shows evolutionary conservation and alignments of the nucleotide sequences for the n class="Species">human GPIHBP1 gene, including the 5′-flanking, 5′-untranslated, intronic, exonic and 3′-untranslated regions of this gene, with the corresponding sequences for 12 mammalian and bird genomes, including 4 primates (e.g., rhesus), 6 non-primate eutherian mammals (e.g., mouse, rat), a marsupial (opossum), a monotreme (platypus) and a bird species (chicken). Extensive conservation was observed among these GPIHBP1 genomic sequences for the eutherian mammalian genomes, particularly for the primate species but also for the exonic and 5′-flanking regions for all eutherian genomes examined. An examination of non-synonymous (ns) single nucleotide polymorphisms (SNPs) within the human genome supported this conclusion of GPIHBP1 conservation with this gene containing only a single ns-SNP within exon 1. In contrast with the eutherian mammalian genomes examined, the opossum (marsupial mammal) genome lacked conserved sequences within the 5′-flanking and exon 1 and 2 regions, but showed some genomic sequence conservation within the exon 3 and exon 4 regions. The platypus (monotreme mammal) exhibited conserved GPIHBP1 gene sequences within the 5′-flanking and exon 3 and 4 regions but showed no conservation of other sections of this gene, and lacked exon 1 and 2 conserved sequences. In addition, the chicken (bird) genomic sequence showed no significant conservation of any region of the GPIHBP1 gene, which is consistent with BLAT analyses undertaken using mammalian GPIHBP1 protein sequences which failed to identify a GPIHBP1 gene in this bird genome. It would appear that GPIHBP1 has only recently evolved during mammalian evolution and that the functional gene is present only in eutherian mammalian genomes.
Fig. 5

Comparative sequences for mammalian 5′-flanking, 5′-untranslated and coding regions for the GPIHBP1 genes. Derived from the UCSC Genome Browser using the Comparative Genomics track to examine alignments and evolutionary conservation of GPIHBP1 gene sequences; genomic sequences aligned for this study included primate (human, orangutan, rhesus and marmoset), non-primate eutherian mammal (mouse, rat, guinea pig, dog, horse and cow), a marsupial (opossum), a monotreme (platypus) and bird species (chicken); conservation measures were based on conserved sequences across all of these species in the alignments which included the 5′-flanking, 5′-untranslated, exons, introns and 3′-untranslated regions for the GPIHBP1 gene; regions of sequence identity are shaded in different colors for different species

Comparative sequences for mammalian 5′-flanking, 5′-untranslated and coding regions for the GPIHBP1 genes. Derived from the UCSC Genome Browser using the Comparative Genomics track to examine alignments and evolutionary conservation of GPIHBP1 gene sequences; genomic sequences aligned for this study included primate (human, orangutan, rhesus and marmoset), non-primate eutherian mammal (mouse, rat, guinea pig, dog, horse and cow), a marsupial (opossum), a monotreme (platypus) and bird species (chicken); conservation measures were based on conserved sequences across all of these species in the alignments which included the 5′-flanking, 5′-untranslated, exons, introns and 3′-untranslated regions for the GPIHBP1 gene; regions of sequence identity are shaded in different colors for different species

Phylogeny and divergence of mammalian GPIHBP1 and LY6-like sequences

A phylogenetic tree (Fig. 6) was calculated by the progressive alignment of 11 mammalian GPIHBP1 amino acid sequences with human, mouse, cow and opossum LY6-like sequences which was ‘rooted’ with the zebrafish (Danio rerio) LYPD6 sequence (Tables 1, 2). The phylogram showed clustering of the sequences into groups which were consistent with their evolutionary relatedness as well as distinct groups for mammalian GPIHBP1 and LY6-like sequences, which were distinct from the zebrafish LYPD6 sequence. In addition, the mammalian LY6-like sequences were further subdivided into groups, including PSCA, LYNX1, LY6D, LY6H, SLURP1, LYPD2, LY6E, LY6K, GML and a group of mouse Ly6-like sequences (designated as Ly6a, Ly6c1, Ly6c2, Ly6f and Ly6i). These groups were significantly different from each other (with bootstrap values >90) and have apparently evolved as distinct genes and proteins during mammalian evolution. Moreover, it is apparent that GPIHBP1 is a distinct but related LY6-like gene which has appeared early in eutherian mammalian evolution.
Fig. 6

Phylogenetic tree of mammalian GPIHBP1 and other LY6-like sequences. The tree is labeled with the gene name and the name of the animal and is ‘rooted’ with the zebrafish (Danio rerio) LY6PD sequence. Note the major cluster for the mammalian GPIHBP1 sequences and several major groups of the other LY6-like sequences: LYNX1, LY6D, LY6H, SLURP1, LYPD2, PSCA, LT6E, LY6K, and GML. A genetic distance scale is shown (% amino acid substitutions). The number of times a clade (sequences common to a node or branch) occurred in the bootstrap replicates are shown. Only replicate values of 90 or more which are highly significant are shown with 100 bootstrap replicates performed in each case

Phylogenetic tree of mammalian n class="Gene">GPIHBP1 and other LY6-like sequences. The tree is labeled with the gene name and the name of the animal and is ‘rooted’ with the zebrafish (Danio rerio) LY6PD sequence. Note the major cluster for the mammalian GPIHBP1 sequences and several major groups of the other LY6-like sequences: LYNX1, LY6D, LY6H, SLURP1, LYPD2, PSCA, LT6E, LY6K, and GML. A genetic distance scale is shown (% amino acid substitutions). The number of times a clade (sequences common to a node or branch) occurred in the bootstrap replicates are shown. Only replicate values of 90 or more which are highly significant are shown with 100 bootstrap replicates performed in each case

Hypothesis: proposed mechanism for the evolutionary appearance of GPIHBP1 in eutherian mammals

A search was undertaken for a potential gene ‘donor’ for the exon encoding the n class="Chemical">acidic amino acid motif contained within the mammalian GPIHBP1 gene using BLAT to interrogate the human genome with the known nucleotide sequence for exon 2 of the human GPIHBP1 gene (Kent et al. 2003). A region of the human BCL11A gene (encoding acidic residues 484–504 of human B-cell CLL/lymphoma 11A) was identified which encoded an extended sequence of acidic amino acids comparable to amino acid residues 25–50 (corresponding to residues encoded by exon 2 of human GPIHBP1) in the human GPIHBP1 sequence. Supplementary Fig. 1 shows an alignment of this region for representative vertebrate BCL11A acidic amino acid sequences with several mammalian GPIHBP1 exon 2 sequences. Similarities in acidic amino acid sequences are apparent although each protein exhibited a distinctive conservation pattern. It may be noted that the BCL11A gene and protein can be traced back to reptiles and fish in vertebrates (Table 3) whereas GPIHBP1 has been only reported in eutherian mammals (Table 1). Previous studies have shown that the mouse Bcl11a gene encodes a C2H2-type zinc-finger protein which is a common site of retroviral integration in myeloid leukemia and functions as a myeloid and B-cell proto-oncogene (Nakamura et al. 2000) and may serve as a candidate gene for the transfer and integration of the acidic amino acid encoding ‘motif’ into the mammalian GPIHBP1 gene. A hypothesis concerning the evolutionary appearance of the ‘ancestral’ eutherian mammalian GPIHBP1 gene is presented in Fig. 7.
Fig. 7

Proposal for generating the GPIHBP1 gene during eutherian mammalian evolution. This hypothesis is for a two-step process for generating the GPIHBP1 gene: (1) a LY6-like gene duplication event in a common ancestor for eutherian mammals; and (2) retroviral transfer of a region of the BCL11A gene in the ancestral genome encoding acidic amino acids generating a GPIHBP1-like gene containing a new exon

Proposal for generating the GPIHBP1 gene during eutherian mammalian evolution. This hypothesis is for a two-step process for generating the GPIHBP1 gene: (1) a LY6-like gene duplication event in a common ancestor for eutherian mammals; and (2) retroviral transfer of a region of the BCL11A gene in the ancestral genome encoding acidic amino acids generating a GPIHBP1-like gene containing a new exon An LY6-like gene within a common ancestor to eutherian mammals underwent a tandem duplication event generating two closely related LY6-like genes. It may be noted that the opossum genome contains similar LY6H genes (designated as LY6H1 and LY6H2) which are closely localized on opossum chromosome 3 (Fig. 3) and form a distinct opossum LY6-like group following CLUSTAL analysis (Fig. 6); and Retroviral integration of the acidic amino acid encoding ‘motif’ of the ancestral BCL11A gene may have occurred in one of the duplicated LY6-like genes (potentially a LY6H-like gene or another LY6-like gene) resulting in the addition of an exon (exon 2) which during the subsequent evolution generates an ancestral eutherian mammalian GPIHBP1-like gene and protein which is retained throughout subsequent eutherian mammalian evolution.

Conclusions

The results of the present study indicate that the mammalian n class="Gene">GPIHBP1 gene and encoded protein recently reported represents a distinct family of lymphocyte antigen-6 (LY6)-related gene and protein which shares key conserved sequences and functions with other LY6-like genes and proteins previously studied (Brakenoff et al. 1995; Capone et al. 1996; Clark et al. 2003; Horie et al. 1998; Ishikawa et al. 2007). GPIHBP1 is encoded by a single gene among the mammalian genomes studied which is localized within a LY6-like gene cluster (~500 kbs) on human chromosome 8 and usually contained 4 coding exons. Predicted secondary structures for mammalian GPIHBP1 proteins showed a strong similarity with other LY6-like proteins in a number of domains, including the N-terminal signal peptide region, the UPAR-LY6 domain and in having a highly hydrophobic C-terminal helical sequence, which is removed in the endoplasmic reticulum during the formation of the glycosylphosphatidylinositol anchor. In contrast, however, all mammalian GPIHBP1 proteins contained two high acidic amino acid regions, which have been proposed to play a role in binding LPL (Beigneux et al. 2007; Gin et al. 2007, 2011). Predicted secondary and tertiary structures of the UPAR-LY6 mammalian GPIHBP1 domain showed a strong resemblance to the corresponding region for the human CD59 antigen structure (Leath et al. 2007) with five anti-parallel β-sheets. Comparative studies of 12 mammalian GPIHBP1 genomic sequences indicated that this gene has appeared during eutherian mammalian evolution with conserved genomic sequences observed for all eutherian mammalian genomes examined. In contrast, GPIHBP1 gene sequences were absent from the chicken genome or were seen only in part for the monotreme and marsupial genomes examined. It is proposed that the GPIHBP1 gene has appeared early in mammalian evolution following a tandem gene duplication event of one of the LY6 genes and the subsequent retroviral integration of exon 2 encoding the acidic amino acid ‘motif’. Below is the link to the n class="Gene">electronic supplementary material. Supplementary Fig. 1: Alignments for Acidic Amino Acid Sequence Regions for Vertebrate BCL11A and Mammalian GPIHBP1 Sequences See Tables 1 and 3 for sources of glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1) and vertebrate BCL11A gene (encoding B-cell CLL/lymphoma 11A) sequences; * shows identical residues for proteins; : similar alternate residues;. dissimilar alternate residues; acidic amino acids are in blue; basic amino acid residues in pink; hydrophobic amino acids in red; and hydrophilic amino acids in green Supplementary material 1 (PPT 139 kb)
  43 in total

1.  The PSIPRED protein structure prediction server.

Authors:  L J McGuffin; K Bryson; D T Jones
Journal:  Bioinformatics       Date:  2000-04       Impact factor: 6.937

2.  Initial sequencing and analysis of the human genome.

Authors:  E S Lander; L M Linton; B Birren; C Nusbaum; M C Zody; J Baldwin; K Devon; K Dewar; M Doyle; W FitzHugh; R Funke; D Gage; K Harris; A Heaford; J Howland; L Kann; J Lehoczky; R LeVine; P McEwan; K McKernan; J Meldrim; J P Mesirov; C Miranda; W Morris; J Naylor; C Raymond; M Rosetti; R Santos; A Sheridan; C Sougnez; Y Stange-Thomann; N Stojanovic; A Subramanian; D Wyman; J Rogers; J Sulston; R Ainscough; S Beck; D Bentley; J Burton; C Clee; N Carter; A Coulson; R Deadman; P Deloukas; A Dunham; I Dunham; R Durbin; L French; D Grafham; S Gregory; T Hubbard; S Humphray; A Hunt; M Jones; C Lloyd; A McMurray; L Matthews; S Mercer; S Milne; J C Mullikin; A Mungall; R Plumb; M Ross; R Shownkeen; S Sims; R H Waterston; R K Wilson; L W Hillier; J D McPherson; M A Marra; E R Mardis; L A Fulton; A T Chinwalla; K H Pepin; W R Gish; S L Chissoe; M C Wendl; K D Delehaunty; T L Miner; A Delehaunty; J B Kramer; L L Cook; R S Fulton; D L Johnson; P J Minx; S W Clifton; T Hawkins; E Branscomb; P Predki; P Richardson; S Wenning; T Slezak; N Doggett; J F Cheng; A Olsen; S Lucas; C Elkin; E Uberbacher; M Frazier; R A Gibbs; D M Muzny; S E Scherer; J B Bouck; E J Sodergren; K C Worley; C M Rives; J H Gorrell; M L Metzker; S L Naylor; R S Kucherlapati; D L Nelson; G M Weinstock; Y Sakaki; A Fujiyama; M Hattori; T Yada; A Toyoda; T Itoh; C Kawagoe; H Watanabe; Y Totoki; T Taylor; J Weissenbach; R Heilig; W Saurin; F Artiguenave; P Brottier; T Bruls; E Pelletier; C Robert; P Wincker; D R Smith; L Doucette-Stamm; M Rubenfield; K Weinstock; H M Lee; J Dubois; A Rosenthal; M Platzer; G Nyakatura; S Taudien; A Rump; H Yang; J Yu; J Wang; G Huang; J Gu; L Hood; L Rowen; A Madan; S Qin; R W Davis; N A Federspiel; A P Abola; M J Proctor; R M Myers; J Schmutz; M Dickson; J Grimwood; D R Cox; M V Olson; R Kaul; C Raymond; N Shimizu; K Kawasaki; S Minoshima; G A Evans; M Athanasiou; R Schultz; B A Roe; F Chen; H Pan; J Ramser; H Lehrach; R Reinhardt; W R McCombie; M de la Bastide; N Dedhia; H Blöcker; K Hornischer; G Nordsiek; R Agarwala; L Aravind; J A Bailey; A Bateman; S Batzoglou; E Birney; P Bork; D G Brown; C B Burge; L Cerutti; H C Chen; D Church; M Clamp; R R Copley; T Doerks; S R Eddy; E E Eichler; T S Furey; J Galagan; J G Gilbert; C Harmon; Y Hayashizaki; D Haussler; H Hermjakob; K Hokamp; W Jang; L S Johnson; T A Jones; S Kasif; A Kaspryzk; S Kennedy; W J Kent; P Kitts; E V Koonin; I Korf; D Kulp; D Lancet; T M Lowe; A McLysaght; T Mikkelsen; J V Moran; N Mulder; V J Pollara; C P Ponting; G Schuler; J Schultz; G Slater; A F Smit; E Stupka; J Szustakowki; D Thierry-Mieg; J Thierry-Mieg; L Wagner; J Wallis; R Wheeler; A Williams; Y I Wolf; K H Wolfe; S P Yang; R F Yeh; F Collins; M S Guyer; J Peterson; A Felsenfeld; K A Wetterstrand; A Patrinos; M J Morgan; P de Jong; J J Catanese; K Osoegawa; H Shizuya; S Choi; Y J Chen; J Szustakowki
Journal:  Nature       Date:  2001-02-15       Impact factor: 49.962

3.  The human genome browser at UCSC.

Authors:  W James Kent; Charles W Sugnet; Terrence S Furey; Krishna M Roskin; Tom H Pringle; Alan M Zahler; David Haussler
Journal:  Genome Res       Date:  2002-06       Impact factor: 9.043

4.  Initial sequencing and comparative analysis of the mouse genome.

Authors:  Robert H Waterston; Kerstin Lindblad-Toh; Ewan Birney; Jane Rogers; Josep F Abril; Pankaj Agarwal; Richa Agarwala; Rachel Ainscough; Marina Alexandersson; Peter An; Stylianos E Antonarakis; John Attwood; Robert Baertsch; Jonathon Bailey; Karen Barlow; Stephan Beck; Eric Berry; Bruce Birren; Toby Bloom; Peer Bork; Marc Botcherby; Nicolas Bray; Michael R Brent; Daniel G Brown; Stephen D Brown; Carol Bult; John Burton; Jonathan Butler; Robert D Campbell; Piero Carninci; Simon Cawley; Francesca Chiaromonte; Asif T Chinwalla; Deanna M Church; Michele Clamp; Christopher Clee; Francis S Collins; Lisa L Cook; Richard R Copley; Alan Coulson; Olivier Couronne; James Cuff; Val Curwen; Tim Cutts; Mark Daly; Robert David; Joy Davies; Kimberly D Delehaunty; Justin Deri; Emmanouil T Dermitzakis; Colin Dewey; Nicholas J Dickens; Mark Diekhans; Sheila Dodge; Inna Dubchak; Diane M Dunn; Sean R Eddy; Laura Elnitski; Richard D Emes; Pallavi Eswara; Eduardo Eyras; Adam Felsenfeld; Ginger A Fewell; Paul Flicek; Karen Foley; Wayne N Frankel; Lucinda A Fulton; Robert S Fulton; Terrence S Furey; Diane Gage; Richard A Gibbs; Gustavo Glusman; Sante Gnerre; Nick Goldman; Leo Goodstadt; Darren Grafham; Tina A Graves; Eric D Green; Simon Gregory; Roderic Guigó; Mark Guyer; Ross C Hardison; David Haussler; Yoshihide Hayashizaki; LaDeana W Hillier; Angela Hinrichs; Wratko Hlavina; Timothy Holzer; Fan Hsu; Axin Hua; Tim Hubbard; Adrienne Hunt; Ian Jackson; David B Jaffe; L Steven Johnson; Matthew Jones; Thomas A Jones; Ann Joy; Michael Kamal; Elinor K Karlsson; Donna Karolchik; Arkadiusz Kasprzyk; Jun Kawai; Evan Keibler; Cristyn Kells; W James Kent; Andrew Kirby; Diana L Kolbe; Ian Korf; Raju S Kucherlapati; Edward J Kulbokas; David Kulp; Tom Landers; J P Leger; Steven Leonard; Ivica Letunic; Rosie Levine; Jia Li; Ming Li; Christine Lloyd; Susan Lucas; Bin Ma; Donna R Maglott; Elaine R Mardis; Lucy Matthews; Evan Mauceli; John H Mayer; Megan McCarthy; W Richard McCombie; Stuart McLaren; Kirsten McLay; John D McPherson; Jim Meldrim; Beverley Meredith; Jill P Mesirov; Webb Miller; Tracie L Miner; Emmanuel Mongin; Kate T Montgomery; Michael Morgan; Richard Mott; James C Mullikin; Donna M Muzny; William E Nash; Joanne O Nelson; Michael N Nhan; Robert Nicol; Zemin Ning; Chad Nusbaum; Michael J O'Connor; Yasushi Okazaki; Karen Oliver; Emma Overton-Larty; Lior Pachter; Genís Parra; Kymberlie H Pepin; Jane Peterson; Pavel Pevzner; Robert Plumb; Craig S Pohl; Alex Poliakov; Tracy C Ponce; Chris P Ponting; Simon Potter; Michael Quail; Alexandre Reymond; Bruce A Roe; Krishna M Roskin; Edward M Rubin; Alistair G Rust; Ralph Santos; Victor Sapojnikov; Brian Schultz; Jörg Schultz; Matthias S Schwartz; Scott Schwartz; Carol Scott; Steven Seaman; Steve Searle; Ted Sharpe; Andrew Sheridan; Ratna Shownkeen; Sarah Sims; Jonathan B Singer; Guy Slater; Arian Smit; Douglas R Smith; Brian Spencer; Arne Stabenau; Nicole Stange-Thomann; Charles Sugnet; Mikita Suyama; Glenn Tesler; Johanna Thompson; David Torrents; Evanne Trevaskis; John Tromp; Catherine Ucla; Abel Ureta-Vidal; Jade P Vinson; Andrew C Von Niederhausern; Claire M Wade; Melanie Wall; Ryan J Weber; Robert B Weiss; Michael C Wendl; Anthony P West; Kris Wetterstrand; Raymond Wheeler; Simon Whelan; Jamey Wierzbowski; David Willey; Sophie Williams; Richard K Wilson; Eitan Winter; Kim C Worley; Dudley Wyman; Shan Yang; Shiaw-Pyng Yang; Evgeny M Zdobnov; Michael C Zody; Eric S Lander
Journal:  Nature       Date:  2002-12-05       Impact factor: 49.962

5.  Molecular evolution and phylogeny of elapid snake venom three-finger toxins.

Authors:  B G Fry; W Wüster; R M Kini; V Brusic; A Khan; D Venkataraman; A P Rooney
Journal:  J Mol Evol       Date:  2003-07       Impact factor: 2.395

6.  Expression cloning and characterization of a novel glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein, GPI-HBP1.

Authors:  Ryoichi X Ioka; Man-Jong Kang; Shin Kamiyama; Dong-Ho Kim; Kenta Magoori; Akihisa Kamataki; Yuichiro Ito; Yumiko A Takei; Masako Sasaki; Takashi Suzuki; Hironobu Sasano; Sadao Takahashi; Juro Sakai; Takahiro Fujino; Tokuo T Yamamoto
Journal:  J Biol Chem       Date:  2002-12-20       Impact factor: 5.157

7.  The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.

Authors:  Hilary F Clark; Austin L Gurney; Evangeline Abaya; Kevin Baker; Daryl Baldwin; Jennifer Brush; Jian Chen; Bernard Chow; Clarissa Chui; Craig Crowley; Bridget Currell; Bethanne Deuel; Patrick Dowd; Dan Eaton; Jessica Foster; Christopher Grimaldi; Qimin Gu; Philip E Hass; Sherry Heldens; Arthur Huang; Hok Seon Kim; Laura Klimowski; Yisheng Jin; Stephanie Johnson; James Lee; Lhney Lewis; Dongzhou Liao; Melanie Mark; Edward Robbie; Celina Sanchez; Jill Schoenfeld; Somasekar Seshagiri; Laura Simmons; Jennifer Singh; Victoria Smith; Jeremy Stinson; Alicia Vagts; Richard Vandlen; Colin Watanabe; David Wieand; Kathryn Woods; Ming-Hong Xie; Daniel Yansura; Sothy Yi; Guoying Yu; Jean Yuan; Min Zhang; Zemin Zhang; Audrey Goddard; William I Wood; Paul Godowski; Alane Gray
Journal:  Genome Res       Date:  2003-09-15       Impact factor: 9.043

8.  Evi9 encodes a novel zinc finger protein that physically interacts with BCL6, a known human B-cell proto-oncogene product.

Authors:  T Nakamura; Y Yamazaki; Y Saiki; M Moriyama; D A Largaespada; N A Jenkins; N G Copeland
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

9.  The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

Authors:  Daniela S Gerhard; Lukas Wagner; Elise A Feingold; Carolyn M Shenmen; Lynette H Grouse; Greg Schuler; Steven L Klein; Susan Old; Rebekah Rasooly; Peter Good; Mark Guyer; Allison M Peck; Jeffery G Derge; David Lipman; Francis S Collins; Wonhee Jang; Steven Sherry; Mike Feolo; Leonie Misquitta; Eduardo Lee; Kirill Rotmistrovsky; Susan F Greenhut; Carl F Schaefer; Kenneth Buetow; Tom I Bonner; David Haussler; Jim Kent; Mark Kiekhaus; Terry Furey; Michael Brent; Christa Prange; Kirsten Schreiber; Nicole Shapiro; Narayan K Bhat; Ralph F Hopkins; Florence Hsie; Tom Driscoll; M Bento Soares; Tom L Casavant; Todd E Scheetz; Michael J Brown-stein; Ted B Usdin; Shiraki Toshiyuki; Piero Carninci; Yulan Piao; Dawood B Dudekula; Minoru S H Ko; Koichi Kawakami; Yutaka Suzuki; Sumio Sugano; C E Gruber; M R Smith; Blake Simmons; Troy Moore; Richard Waterman; Stephen L Johnson; Yijun Ruan; Chia Lin Wei; S Mathavan; Preethi H Gunaratne; Jiaqian Wu; Angela M Garcia; Stephen W Hulyk; Edwin Fuh; Ye Yuan; Anna Sneed; Carla Kowis; Anne Hodgson; Donna M Muzny; John McPherson; Richard A Gibbs; Jessica Fahey; Erin Helton; Mark Ketteman; Anuradha Madan; Stephanie Rodrigues; Amy Sanchez; Michelle Whiting; Anup Madari; Alice C Young; Keith D Wetherby; Steven J Granite; Peggy N Kwong; Charles P Brinkley; Russell L Pearson; Gerard G Bouffard; Robert W Blakesly; Eric D Green; Mark C Dickson; Alex C Rodriguez; Jane Grimwood; Jeremy Schmutz; Richard M Myers; Yaron S N Butterfield; Malachi Griffith; Obi L Griffith; Martin I Krzywinski; Nancy Liao; Ryan Morin; Ryan Morrin; Diana Palmquist; Anca S Petrescu; Ursula Skalska; Duane E Smailus; Jeff M Stott; Angelique Schnerch; Jacqueline E Schein; Steven J M Jones; Robert A Holt; Agnes Baross; Marco A Marra; Sandra Clifton; Kathryn A Makowski; Stephanie Bosak; Joel Malek
Journal:  Genome Res       Date:  2004-10       Impact factor: 9.043

10.  Genome sequence of the Brown Norway rat yields insights into mammalian evolution.

Authors:  Richard A Gibbs; George M Weinstock; Michael L Metzker; Donna M Muzny; Erica J Sodergren; Steven Scherer; Graham Scott; David Steffen; Kim C Worley; Paula E Burch; Geoffrey Okwuonu; Sandra Hines; Lora Lewis; Christine DeRamo; Oliver Delgado; Shannon Dugan-Rocha; George Miner; Margaret Morgan; Alicia Hawes; Rachel Gill; Robert A Holt; Mark D Adams; Peter G Amanatides; Holly Baden-Tillson; Mary Barnstead; Soo Chin; Cheryl A Evans; Steve Ferriera; Carl Fosler; Anna Glodek; Zhiping Gu; Don Jennings; Cheryl L Kraft; Trixie Nguyen; Cynthia M Pfannkoch; Cynthia Sitter; Granger G Sutton; J Craig Venter; Trevor Woodage; Douglas Smith; Hong-Mei Lee; Erik Gustafson; Patrick Cahill; Arnold Kana; Lynn Doucette-Stamm; Keith Weinstock; Kim Fechtel; Robert B Weiss; Diane M Dunn; Eric D Green; Robert W Blakesley; Gerard G Bouffard; Pieter J De Jong; Kazutoyo Osoegawa; Baoli Zhu; Marco Marra; Jacqueline Schein; Ian Bosdet; Chris Fjell; Steven Jones; Martin Krzywinski; Carrie Mathewson; Asim Siddiqui; Natasja Wye; John McPherson; Shaying Zhao; Claire M Fraser; Jyoti Shetty; Sofiya Shatsman; Keita Geer; Yixin Chen; Sofyia Abramzon; William C Nierman; Paul H Havlak; Rui Chen; K James Durbin; Amy Egan; Yanru Ren; Xing-Zhi Song; Bingshan Li; Yue Liu; Xiang Qin; Simon Cawley; Kim C Worley; A J Cooney; Lisa M D'Souza; Kirt Martin; Jia Qian Wu; Manuel L Gonzalez-Garay; Andrew R Jackson; Kenneth J Kalafus; Michael P McLeod; Aleksandar Milosavljevic; Davinder Virk; Andrei Volkov; David A Wheeler; Zhengdong Zhang; Jeffrey A Bailey; Evan E Eichler; Eray Tuzun; Ewan Birney; Emmanuel Mongin; Abel Ureta-Vidal; Cara Woodwark; Evgeny Zdobnov; Peer Bork; Mikita Suyama; David Torrents; Marina Alexandersson; Barbara J Trask; Janet M Young; Hui Huang; Huajun Wang; Heming Xing; Sue Daniels; Darryl Gietzen; Jeanette Schmidt; Kristian Stevens; Ursula Vitt; Jim Wingrove; Francisco Camara; M Mar Albà; Josep F Abril; Roderic Guigo; Arian Smit; Inna Dubchak; Edward M Rubin; Olivier Couronne; Alexander Poliakov; Norbert Hübner; Detlev Ganten; Claudia Goesele; Oliver Hummel; Thomas Kreitler; Young-Ae Lee; Jan Monti; Herbert Schulz; Heike Zimdahl; Heinz Himmelbauer; Hans Lehrach; Howard J Jacob; Susan Bromberg; Jo Gullings-Handley; Michael I Jensen-Seaman; Anne E Kwitek; Jozef Lazar; Dean Pasko; Peter J Tonellato; Simon Twigger; Chris P Ponting; Jose M Duarte; Stephen Rice; Leo Goodstadt; Scott A Beatson; Richard D Emes; Eitan E Winter; Caleb Webber; Petra Brandt; Gerald Nyakatura; Margaret Adetobi; Francesca Chiaromonte; Laura Elnitski; Pallavi Eswara; Ross C Hardison; Minmei Hou; Diana Kolbe; Kateryna Makova; Webb Miller; Anton Nekrutenko; Cathy Riemer; Scott Schwartz; James Taylor; Shan Yang; Yi Zhang; Klaus Lindpaintner; T Dan Andrews; Mario Caccamo; Michele Clamp; Laura Clarke; Valerie Curwen; Richard Durbin; Eduardo Eyras; Stephen M Searle; Gregory M Cooper; Serafim Batzoglou; Michael Brudno; Arend Sidow; Eric A Stone; J Craig Venter; Bret A Payseur; Guillaume Bourque; Carlos López-Otín; Xose S Puente; Kushal Chakrabarti; Sourav Chatterji; Colin Dewey; Lior Pachter; Nicolas Bray; Von Bing Yap; Anat Caspi; Glenn Tesler; Pavel A Pevzner; David Haussler; Krishna M Roskin; Robert Baertsch; Hiram Clawson; Terrence S Furey; Angie S Hinrichs; Donna Karolchik; William J Kent; Kate R Rosenbloom; Heather Trumbower; Matt Weirauch; David N Cooper; Peter D Stenson; Bin Ma; Michael Brent; Manimozhiyan Arumugam; David Shteynberg; Richard R Copley; Martin S Taylor; Harold Riethman; Uma Mudunuri; Jane Peterson; Mark Guyer; Adam Felsenfeld; Susan Old; Stephen Mockrin; Francis Collins
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

View more
  13 in total

1.  Evidence for Two Distinct Binding Sites for Lipoprotein Lipase on Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein 1 (GPIHBP1).

Authors:  Mart Reimund; Mikael Larsson; Oleg Kovrov; Sergo Kasvandik; Gunilla Olivecrona; Aivar Lookene
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

2.  Lipoprotein lipase reaches the capillary lumen in chickens despite an apparent absence of GPIHBP1.

Authors:  Cuiwen He; Xuchen Hu; Rachel S Jung; Mikael Larsson; Yiping Tu; Sandra Duarte-Vogel; Paul Kim; Norma P Sandoval; Tara R Price; Christopher M Allan; Brian Raney; Haibo Jiang; André Bensadoun; Rosemary L Walzem; Richard I Kuo; Anne P Beigneux; Loren G Fong; Stephen G Young
Journal:  JCI Insight       Date:  2017-10-19

Review 3.  Biochemistry and pathophysiology of intravascular and intracellular lipolysis.

Authors:  Stephen G Young; Rudolf Zechner
Journal:  Genes Dev       Date:  2013-03-01       Impact factor: 11.361

Review 4.  GPIHBP1 and Plasma Triglyceride Metabolism.

Authors:  Loren G Fong; Stephen G Young; Anne P Beigneux; André Bensadoun; Monika Oberer; Haibo Jiang; Michael Ploug
Journal:  Trends Endocrinol Metab       Date:  2016-05-14       Impact factor: 12.015

Review 5.  Organization, evolution and functions of the human and mouse Ly6/uPAR family genes.

Authors:  Chelsea L Loughner; Elspeth A Bruford; Monica S McAndrews; Emili E Delp; Sudha Swamynathan; Shivalingappa K Swamynathan
Journal:  Hum Genomics       Date:  2016-04-21       Impact factor: 4.639

6.  Genetic risk variants for metabolic traits in Arab populations.

Authors:  Prashantha Hebbar; Naser Elkum; Fadi Alkayal; Sumi Elsa John; Thangavel Alphonse Thanaraj; Osama Alsmadi
Journal:  Sci Rep       Date:  2017-01-20       Impact factor: 4.379

Review 7.  Evolution and Medical Significance of LU Domain-Containing Proteins.

Authors:  Julie Maja Leth; Katrine Zinck Leth-Espensen; Kristian Kølby Kristensen; Anni Kumari; Anne-Marie Lund Winther; Stephen G Young; Michael Ploug
Journal:  Int J Mol Sci       Date:  2019-06-05       Impact factor: 5.923

Review 8.  Relating GPI-Anchored Ly6 Proteins uPAR and CD59 to Viral Infection.

Authors:  Jingyou Yu; Vaibhav Murthy; Shan-Lu Liu
Journal:  Viruses       Date:  2019-11-14       Impact factor: 5.048

9.  Structural Analysis and Deletion Mutagenesis Define Regions of QUIVER/SLEEPLESS that Are Responsible for Interactions with Shaker-Type Potassium Channels and Nicotinic Acetylcholine Receptors.

Authors:  Meilin Wu; Clifford Z Liu; William J Joiner
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

Review 10.  Hypertriglyceridemia and Atherosclerosis: Using Human Research to Guide Mechanistic Studies in Animal Models.

Authors:  Debapriya Basu; Karin E Bornfeldt
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-06       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.